Page last updated: 2024-08-26

carbidopa, levodopa drug combination and Heart Valve Diseases

carbidopa, levodopa drug combination has been researched along with Heart Valve Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burkhard, PR; Flachsbart, KD; Fross, RD; Horvath, J; Kleiner-Fisman, G; Lang, AE; Lerch, R; Liaudat, S; Pache, JC; Rakowski, H; Raskoff, WJ; Stalder, H1

Other Studies

1 other study(ies) available for carbidopa, levodopa drug combination and Heart Valve Diseases

ArticleYear
Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:6

    Topics: Adult; Aged; Cabergoline; Carbidopa; Dopamine Agonists; Drug Combinations; Echocardiography, Transesophageal; Ergolines; Ergot Alkaloids; Female; Heart Valve Diseases; Humans; Levodopa; Male; Parkinson Disease; Pergolide

2004